Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
3.53
-0.23 (-6.12%)
At close: Aug 15, 2025, 3:59 PM
3.50
-0.85%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sonnet BioTherapeutics Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 1M | 1M | 1M | 18.63K | 55.88K | 92.73K | 129.18K | 147.81K | 173.3K | 198.52K | 257.4K | 349.94K | 770.82K | 708.75K | 613.42K | 483.63K | -5.68M | -5.68M | n/a |
Cost of Revenue | 65.89K | 86.93K | 85.33K | 83.11K | 80.97K | 78.91K | 77.29K | 75.75K | 74.21K | 5.7M | 12.09M | 12.1M | 17.12M | 11.49M | 5.11M | 8.95M | 5.71M | 5.69M | 7.46M |
Gross Profit | 956.3K | 935.26K | 936.86K | -64.49K | -25.09K | 13.82K | 51.89K | 72.06K | 99.09K | -5.51M | -11.83M | -11.75M | -16.34M | -10.78M | -4.5M | -8.47M | -11.39M | -11.37M | -7.46M |
Operating Income | -14.06M | -13.78M | -13.42M | -11.85M | -12.28M | -12.66M | -14.46M | -18.79M | -22.57M | -26.52M | -29.07M | -29.67M | -29.24M | -27.61M | -25.44M | -25.09M | -25.63M | -31.16M | -26.48M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.4M | -13.13M | -9.27M | -7.44M | -7.99M | -8.43M | -14.46M | -18.83M | -22.59M | -26.52M | -29.06M | -29.72M | -29.24M | -27.48M | -25.31M | -24.98M | -25.55M | -31.22M | -26.97M |
Net Income | -13.56M | -13.29M | -9.43M | -7.44M | -7.99M | -8.43M | -14.46M | -18.83M | -22.65M | -26.59M | -29.13M | -29.76M | -29.22M | -27.45M | -25.28M | -24.98M | -25.55M | -31.22M | -27.1M |
Selling & General & Admin | 7.66M | 8.08M | 7.44M | 6.13M | 5.95M | 5.69M | 5.88M | 7.13M | 7.65M | 8.38M | 8.4M | 8.58M | 8.65M | 8.73M | 9.02M | 8.94M | 9.33M | 9.46M | 8.44M |
Research & Development | 7.4M | 6.7M | 6.98M | 5.74M | 6.38M | 7.06M | 8.71M | 11.81M | 15.1M | 18.34M | 20.92M | 21.44M | 21.36M | 19.59M | 17.03M | 16.63M | 16.3M | 14.87M | 12.34M |
Other Expenses | -21.61K | -21.61K | -20.88K | -21.38K | -19.24K | -19.24K | -19.96K | -19.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.06M | -4.06M | -4.04M |
Operating Expenses | 15.04M | 14.76M | 14.4M | 11.85M | 12.31M | 12.74M | 14.57M | 18.92M | 22.74M | 26.72M | 29.32M | 30.02M | 30.01M | 28.32M | 26.05M | 25.57M | 25.63M | 24.33M | 23.53M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58.38K | 68.17K | 68.17K | 68.17K | 9.79K | n/a | n/a | n/a | n/a | 3.8K | 166.79K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 286.71K |
Cost & Expenses | 11.25M | 14.78M | 14.42M | 11.87M | 12.33M | 12.76M | 14.59M | 18.94M | 22.74M | 26.72M | 29.32M | 30.02M | 30.01M | 28.32M | 26.05M | 25.57M | 25.63M | 24.33M | 25.33M |
Income Tax Expense | 158.4K | 158.4K | 158.4K | n/a | n/a | 31.43K | 36.04K | 36.04K | 94.41K | 72.78K | 66.45K | 38.51K | -14.68K | -22.96K | -19.16K | 22.02K | 20.51K | 19K | 13.25K |
Shares Outstanding (Basic) | 3.97M | 3.92M | 2.02M | 650.28K | 629.69K | 577.21K | 474.72K | 218.8K | 166.91K | 93.83K | 39.32K | 25.45K | 24.61K | 24.47K | 24.47K | 9.55K | 9.13K | 7.61K | 6.99K |
Shares Outstanding (Diluted) | 3.97M | 3.92M | 2.02M | 650.28K | 629.69K | 577.21K | 474.72K | 218.8K | 166.91K | 93.83K | 39.32K | 25.45K | 24.61K | 24.47K | 24.47K | 9.55K | 9.13K | 7.61K | 6.99K |
EPS (Basic) | -8.21 | -12.83 | -11.31 | -12.21 | -24.2 | -42.28 | -103.3 | -241.78 | -517.15 | -813.65 | -1.09K | -1.2K | -1.64K | -1.99K | -2.45K | -3.03K | -13.98K | -15.88K | -25.58K |
EPS (Diluted) | -8.21 | -12.83 | -11.31 | -12.21 | -24.2 | -42.28 | -103.3 | -241.78 | -517.15 | -813.65 | -1.09K | -1.2K | -1.64K | -1.99K | -2.45K | -3.03K | -13.98K | -15.88K | -25.58K |
EBITDA | -13.99M | -13.69M | -13.33M | -11.77M | -12.2M | -12.58M | -14.38M | -18.72M | -22.5M | -26.44M | -28.98M | -29.58M | -29.14M | -27.51M | -25.34M | -24.99M | -25.54M | -24.26M | -19.05M |
EBIT | -10.25M | -13.78M | -13.42M | -11.85M | -12.28M | -12.66M | -14.46M | -18.79M | -22.57M | -26.52M | -29.07M | -29.67M | -29.24M | -27.61M | -25.44M | -25.09M | -25.63M | -24.33M | -19.93M |
Depreciation & Amortization | 65.89K | 86.93K | 85.33K | 83.11K | 80.97K | 78.91K | 77.29K | 75.75K | 74.21K | 78.93K | 86.24K | 93.26K | 100.11K | 100.49K | 97.81K | 95.16K | 92.61K | 71.62K | 875.47K |